197 related articles for article (PubMed ID: 29848166)
41. Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes.
Piantoni S; Regola F; Zanola A; Andreoli L; Dall'Ara F; Tincani A; Airo' P
Lupus; 2018 Jan; 27(1):143-149. PubMed ID: 28764616
[TBL] [Abstract][Full Text] [Related]
42. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
[TBL] [Abstract][Full Text] [Related]
43. Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus.
Zhu H; Mi W; Luo H; Chen T; Liu S; Raman I; Zuo X; Li QZ
Arthritis Res Ther; 2016 Jul; 18():162. PubMed ID: 27412348
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive long non-coding RNA expression profiling reveals their potential roles in systemic lupus erythematosus.
Li LJ; Zhao W; Tao SS; Li J; Xu SZ; Wang JB; Leng RX; Fan YG; Pan HF; Ye DQ
Cell Immunol; 2017 Sep; 319():17-27. PubMed ID: 28622785
[TBL] [Abstract][Full Text] [Related]
45. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
[TBL] [Abstract][Full Text] [Related]
46. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity.
Herndon TM; Juang YT; Solomou EE; Rothwell SW; Gourley MF; Tsokos GC
Clin Immunol; 2002 May; 103(2):145-53. PubMed ID: 12027419
[TBL] [Abstract][Full Text] [Related]
47. SiLEncing SLE: the power and promise of small noncoding RNAs.
Rigby RJ; Vinuesa CG
Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172
[TBL] [Abstract][Full Text] [Related]
48. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
Rozo C; Chinenov Y; Maharaj RK; Gupta S; Leuenberger L; Kirou KA; Bykerk VP; Goodman SM; Salmon JE; Pernis AB
Ann Rheum Dis; 2017 Apr; 76(4):740-747. PubMed ID: 28283529
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4
Liao W; Li M; Wu H; Jia S; Zhang N; Dai Y; Zhao M; Lu Q
Clin Epigenetics; 2017; 9():104. PubMed ID: 29018507
[TBL] [Abstract][Full Text] [Related]
50. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray.
Han GM; Chen SL; Shen N; Ye S; Bao CD; Gu YY
Genes Immun; 2003 Apr; 4(3):177-86. PubMed ID: 12700592
[TBL] [Abstract][Full Text] [Related]
51. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
[TBL] [Abstract][Full Text] [Related]
52. Diminished levels of protein kinase A RI alpha and RI beta transcripts and proteins in systemic lupus erythematosus T lymphocytes.
Laxminarayana D; Khan IU; Mishra N; Olorenshaw I; Taskén K; Kammer GM
J Immunol; 1999 May; 162(9):5639-48. PubMed ID: 10228048
[TBL] [Abstract][Full Text] [Related]
53. Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.
Comte D; Karampetsou MP; Yoshida N; Kis-Toth K; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2017 May; 69(5):1035-1044. PubMed ID: 28076903
[TBL] [Abstract][Full Text] [Related]
54. Upregulated BclG(L) expression enhances apoptosis of peripheral blood CD4+ T lymphocytes in patients with systemic lupus erythematosus.
Luo N; Wu Y; Chen Y; Yang Z; Guo S; Fei L; Zhou D; Yang C; Wu S; Ni B; Hao F; Wu Y
Clin Immunol; 2009 Sep; 132(3):349-61. PubMed ID: 19524489
[TBL] [Abstract][Full Text] [Related]
55. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.
Liossis SN; Ding XZ; Dennis GJ; Tsokos GC
J Clin Invest; 1998 Apr; 101(7):1448-57. PubMed ID: 9525988
[TBL] [Abstract][Full Text] [Related]
56. Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1.
Kono M; Kurita T; Yasuda S; Kono M; Fujieda Y; Bohgaki T; Katsuyama T; Tsokos GC; Moulton VR; Atsumi T
Arthritis Rheumatol; 2018 Dec; 70(12):2046-2056. PubMed ID: 29905030
[TBL] [Abstract][Full Text] [Related]
57. Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes.
Mishra N; Khan IU; Tsokos GC; Kammer GM
J Immunol; 2000 Sep; 165(5):2830-40. PubMed ID: 10946316
[TBL] [Abstract][Full Text] [Related]
58. Differential expression of estrogen receptors in women with systemic lupus erythematosus.
Rider V; Li X; Peterson G; Dawson J; Kimler BF; Abdou NI
J Rheumatol; 2006 Jun; 33(6):1093-101. PubMed ID: 16755656
[TBL] [Abstract][Full Text] [Related]
59. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
60. Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity.
Crispín JC; Keenan BT; Finnell MD; Bermas BL; Schur P; Massarotti E; Karlson EW; Fitzgerald LM; Ergin S; Kyttaris VC; Tsokos GC; Costenbader KH
Arthritis Rheum; 2010 May; 62(5):1431-7. PubMed ID: 20213807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
